Eclipse Introduces Smooth Cool HR/SR with Unique Chilling ... ( DALLAS Sept. 17 /- ...)

Eclipse Introduces Smooth Cool HR/SR with Unique Chilling Technology

Date:9/17/2009

DALLAS, Sept. 17 /PRNewswire/ -- Eclipse, the leading US national distributor of advanced medical and aesthetic devices, introduces Smooth Cool HR/SR, a world-class technology that's proven to be a best in class player in the light based hair removal market. Smooth Cool HR/SR will make its US debut at the ASDS conference in Phoenix Arizona October first thru third. "Smooth Cool HR/SR is designed for the practitioner who demands an efficient and reliable hair removal workhorse. Eclipse expects Smooth Cool to become one of the elite hair removal devices within the US aesthetic space because of its unique skin cooling capabilities which ultimately allows for the safe delivery of large peak doses of power for maximum hair removal efficacy," says Tom O'Brien, Eclipse CEO.

The built-in chilling technology of Smooth Cool is what sets it apart from existing laser and IPL (Intense Pulsed Light) devices. Smooth Cool, unlike other light devices has mastered the proper means for keeping the skin cool which allows for optimal delivery of energy to the target safely. Hair removal with Smooth Cool works faster, covers a larger surface area and removes the deepest hair follicles with minimal discomfort and maximum safety. The Smooth Cool is ideal for meeting the demands of the most challenging hair removal cases.

About Smooth Cool HR/SR's Chilling Technology: The ATC (Automatic Temperature Controller) feature gives the best solution for body and facial hair removal such as female upper lip hair, providing perfect protection of the epidermis. The hand piece of the Smooth Cool system cools the skin quickly, which protects the skin from thermal injury. Smooth Cool with ATC provides the best cooling advancement known to date.

Additionally, Smooth Cool has been submitted for FDA clearance for photo skin rejuvenation. Eclipse anticipates confirmation of this clearance in
'/>"/>

SOURCE Eclipsemed Ltd
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Eclipsemed, Ltd to Introduce EndyMed PRO(TM) to U.S. Aesthetic Market
2. eCube Systems Brings Remote Eclipse Development to HP OpenVMS
3. ExoSeal vascular plug gets good reviews in ECLIPSE study
4. Eclipse(TM) Proton Scanning Algorithm from Varian Medical Systems Receives FDA Clearance
5. Thermage, Inc. Announces Distribution Agreement With Eclipse Medical, Ltd.
6. Wrigleys Orbit(R), Extra(R) and Eclipse(R) Sugar-Free Chewing Gums Awarded American Dental Associations Seal of Acceptance
7. ECLIPSE data on effects of Otsukas investigational novel treatment, Tolvaptan
8. Kaiser Permanente Introduces New Ad, Re-launches Two Previous Ads
9. Align Technology Introduces Innovative New Features for Invisalign(R) Products
10. UK's Newcastle University Introduces First-Ever Biopharmaceutical Engineering Doctorate Program
11. Universal Medical Systems of Ohio Introduces Charlie, Worlds First Portable, Battery-Operated, Multi-Slice CT Scanner for Pets

Post Your Comments:

(Date:5/22/2012)... Women who are unable to quit smoking during ... their newborns by taking Vitamin C daily, according ... Science University Doernbecher Children,s Hospital. , "Smoking during ... development of the developing baby, causing lifelong decreased ... said Cindy McEvoy, M.D., M.C.R., neonatologist and associate ...

(Date:5/22/2012)... 22 (HealthDay News) -- Colonoscopies helped doctors detect ... people who had the screening for the first ... suggest that screenings should be made available to ... tested, Dr. Therese Kerwel, research fellow at Grand ... Health Medical Group in Grand Rapids, Mich., concluded. ...

(Date:5/22/2012)... College of Wisconsin have identified novel biomarkers that could ... large groups of people potentially exposed to unknown and ... , The findings are published in the May 1 ... Baker, Ph.D., professor of surgery, biochemistry, pharmacology and toxicology ... author of the study. , There is an urgent ...

(Date:5/22/2012)... HealthDay Reporter , , MONDAY, May 21 (HealthDay ... to unleash heated debate, a prominent U.S. government ... ages no longer be screened for prostate cancer ... The U.S. Preventive Services Task Force, an ... evidence-based medicine, said PSA screening results in overdiagnosis ...

(Date:5/22/2012)... gene variants linked to prostate cancer may make ... according to a new study. On the other ... those symptoms, the study found. Researchers ... University in Chicago identified 38 genetic sequence variants ... healthy, white men enrolled in a prostate cancer ...

Breaking Medicine News(10 mins):Health News:Vitamin C improves lung function in newborns of pregnant smoking women 2 Health News:Colonoscopy May Detect Curable Cancer in Elderly: Study 2 Health News:U.S. Advisers Say 'No' to Routine PSA Tests for Prostate Cancer 2 Health News:U.S. Advisers Say 'No' to Routine PSA Tests for Prostate Cancer 3 Health News:Study Ties Genes to Lower Urinary Tract Symptoms, Prostate Cancer Risk 2

[0] Vitamin C improves lung function in newborns of pregnant smoking women [0] Colonoscopy May Detect Curable Cancer in Elderly: Study [0] Novel biomarkers reveal evidence of radiation exposure [0] U.S. Advisers Say 'No' to Routine PSA Tests for Prostate Cancer [0] Study Ties Genes to Lower Urinary Tract Symptoms, Prostate Cancer Risk

... A medication that helps stop the growth of new ... with aggressive thyroid cancer, research from Mayo Clinic indicates. ... Society of Clinical Oncology (ASCO), Mayo investigators report ... aggressive differentiated thyroid cancer treated with the drug pazopanib ...

... DataNew Data Reinforce Importance of Infection Prevention in ... New Data in Multiple Tumor TypesTHOUSAND OAKS, Calif., ... ) today announced it will present new data ... investigational cancer products at the 2009 American Society ...

... --, - Third Quarter 2009 Revenue Increased 7.4% to $9.9 ... Million with EPS of $0.10, - Revenue for the First ... Income Increased 29.2% to $5.7 Million with EPS of $0.23, ... - Cash Flow from Operations Increased 150.6% to $4.4 million for ...

... ,s Next-Generation Solution To Revolutionize Receivables Management Industry ... /PRNewswire/ -- Ontario Systems, a leading ... solutions for the health care and debt management ... with Microsoft Corporation that will strengthen Ontario Systems, ...

... Organization for Rare Disorders (NORD) Recognizes BioMarin,s Efforts to ... 15 BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ... Corporate Award from the National Organization for Rare Disorders ... people with rare diseases. The award was presented on ...

... about genetic risks fosters openness, expert says , , FRIDAY, May ... to decide what to share with their children. But when ... study shows that those who choose to reveal the results ... know that two genes are to blame for the majority ...

Drug that targets vasculature growth attacks aggressive thyroid cancer Amgen Highlights Data to Be Presented at ASCO Tianyin Pharmaceutical Co., Inc. Announces Third Quarter 2009 Financial Results Ontario Systems Announces New Alliance With Microsoft BioMarin Receives 2009 Corporate Award for the Development of Kuvan Sharing Cancer Info May Be Empowering

(Date:5/22/2012)... -- MusclePharm Corporation (OTCBB: MSLP.OB), a nutritional supplement company ... has signed Major League Baseball phenom Bryce Harper ... not disclosed. Harper, a 19-year-old star ... baseball debut on April 28. He previously was ... baseball draft, after earning the 2010 Golden Spikes ...

(Date:5/22/2012)... Upsher-Smith Laboratories, Inc. announced today that Senior ... McKesson Branded Pharmaceutical Representative of the Year Award ... Las Vegas, NV on May 8, 2012. The ... President of Purchasing at McKesson. ... CA-based McKesson, one of the largest pharmaceutical distributors ...

(Date:5/22/2012)... -- Medical Alarm Concepts Holding, Inc. (OTCQB: MDHI.PK), today ... ever set of orders for the MediPendant™ personal medical ... user to speak and listen directly through the pendant. ... of this order resulted in revenue to the company ... same customer through the end of the year, as ...

Breaking Medicine Technology:MusclePharm Signs Pro Baseball Rookie Phenom Bryce Harper As Sponsored Athlete 2 Dave Zitnak Of Upsher-Smith Laboratories Named Branded Representative Of The Year By McKesson Corporation 2 Medical Alarm Begins Revenue Recognition from Largest Set of Orders -- Releases New Television Commercial 2 Medical Alarm Begins Revenue Recognition from Largest Set of Orders -- Releases New Television Commercial 3 Payless and Shoppers Take Steps In the Fight Against Breast Cancer This October 57984 1 Payless and Shoppers Take Steps In the Fight Against Breast Cancer This October 57984 2 Payless and Shoppers Take Steps In the Fight Against Breast Cancer This October 57984 3 Payless and Shoppers Take Steps In the Fight Against Breast Cancer This October 57984 4 Osseon Signs International Distribution Agreement With MBA Incorporado 57980 1 Osseon Signs International Distribution Agreement With MBA Incorporado 57980 2 Osseon Signs International Distribution Agreement With MBA Incorporado 57980 3 New Reagents from New England Biolabs Bring Purity and Increased Value to Sample Prep for Next Generation Sequencing 57976 1

[0] MusclePharm Signs Pro Baseball Rookie Phenom Bryce Harper As Sponsored Athlete [0] Dave Zitnak Of Upsher-Smith Laboratories Named Branded Representative Of The Year By McKesson Corporation [0] Medical Alarm Begins Revenue Recognition from Largest Set of Orders -- Releases New Television Commercial

... Calif., Dec. 2 TorreyPines Therapeutics, Inc. (Nasdaq: ... Phase II trial evaluating three doses of NGX267 as a ... syndrome. NGX267 met the primary endpoint of a statistically ... all three doses: 10 mg, 15 mg, and 20 mg. ...

... 2 A study has found that positron emission mammography ... affected by either breast density or a woman,s hormonal status, ... MRI at detecting cancer. Results will be presented today at ... (RSNA). , , "The ...

Other Medicine Technology:TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 2 TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 3 TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 4 TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 5 New Mammography Technology Effective in Detecting Breast Cancer 2 New Mammography Technology Effective in Detecting Breast Cancer 3 New Mammography Technology Effective in Detecting Breast Cancer 4

TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia New Mammography Technology Effective in Detecting Breast Cancer

... the system of choice for customers performing ... medium throughput laboratories in more than 50 ... Dade Behring is pleased to announce the ... ,The customer centered development process of ...

... OSCAR ulitizes ultrasonic waves to remove bone cement ... the probe liquifies the cement at the point ... minutes. , ,A special feature of the apparatus ... and to signal this to the operator instantly. ...

The Universal Knee Positioner(s)™ reduces surgeon fatigue while assisting in the stabilization of a patient's leg during surgury....

... Like other blood salvage devices, the ... blood cells lost during and after surgery, ... its kind designed specifically to adapt to ... surgical patients. The system consists of single-patient ...

Medicine Products:

BN ProSpec System OSCAR Ultrasonic Bone Cement Remover Universal Knee Positioner™OrthoPAT System

Eclipse Introduces Smooth Cool HR/SR with Unique Chilling ...( DALLAS Sept. 17 /- ...),Health